Ophthalmic implants - Ophthalmic viscosurgical devices (ISO 15798:2022)
1Key Takeaways
The DIN EN ISO 15798:2022 standard, titled "Ophthalmic implants - Ophthalmic viscosurgical devices (ISO 15798:2022)," provides comprehensive guidelines and specifications for ophthalmic viscosurgical devices (OVDs) used in eye surgery. These devices are essential in various ophthalmic procedures, particularly in catar…
2Scope / Description
The DIN EN ISO 15798:2022 standard, titled "Ophthalmic implants - Ophthalmic viscosurgical devices (ISO 15798:2022)," provides comprehensive guidelines and specifications for ophthalmic viscosurgical devices (OVDs) used in eye surgery. These devices are essential in various ophthalmic procedures, particularly in cataract surgery, where they help maintain the anterior chamber, protect corneal endothelial cells, and facilitate the manipulation of intraocular tissues. The standard outlines the requirements for the physical, chemical, and biological properties of OVDs, ensuring their safety and efficacy in clinical use.
This standard is applicable to both single-use and reusable OVDs, covering aspects such as rheological properties, sterility, and biocompatibility. It also includes detailed test methods for evaluating the performance of these devices, ensuring that they meet the necessary criteria for use in ophthalmic surgery. By adhering to the DIN EN ISO 15798:2022 standard, manufacturers can ensure that their products are of high quality and safe for patient use, while healthcare providers can be confident in the reliability and effectiveness of the OVDs they employ in surgical procedures.
Furthermore, the standard emphasizes the importance of labeling and instructions for use, providing clear guidance to practitioners on the proper handling and application of OVDs. This helps to minimize risks and enhance the overall success rate of ophthalmic surgeries. The DIN EN ISO 15798:2022 standard is a critical tool for ensuring the safety and efficacy of ophthalmic viscosurgical devices, contributing to improved patient outcomes in eye surgery.